Rhode Island 2024 Regular Session

Rhode Island Senate Bill S2076

Introduced
1/12/24  
Refer
1/12/24  
Report Pass
2/15/24  
Engrossed
3/7/24  

Caption

Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.

Impact

The impact of S2076 on state laws is substantial, effectively amending existing statutes to guarantee that all group health insurance policies issued in Rhode Island continue to provide coverage for the identified pediatric disorders. By eliminating the sunset provision, the bill mandates that health insurance carriers adhere to coverage requirements indefinitely rather than allowing for a potential lapse. This legislative alteration emphasizes the state's commitment to ensuring ongoing support and treatment funding for these vulnerable pediatric populations.

Summary

Senate Bill S2076 proposes significant changes to the existing statutory provisions governing insurance coverage for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome. Specifically, the bill aims to remove the current sunset clause that mandates coverage for these conditions, thus extending insurance obligations beyond the previously established expiration date of December 31, 2025. This change is critical as it ensures that affected children continue to receive necessary medical care without gaps in their insurance protection.

Contention

As with many healthcare-related legislative measures, there are points of contention regarding S2076. Advocates for the bill argue that continued coverage for pediatric autoimmune neuropsychiatric disorders is necessary given the significant mental health impacts and the need for comprehensive treatment options, including intravenous immunoglobulin therapy. Conversely, some stakeholders might raise concerns about the financial implications for health insurance carriers and potential challenges in managing the cost of treatments, thus sparking a broader discussion about healthcare expenditures and fiscal responsibility.

Companion Bills

No companion bills found.

Similar Bills

RI S0473

Extends coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome by removing the sunset date of December 31, 2025, and mandating such coverage.

RI H5625

Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.

RI H5256

Accident And Sickness Insurance Policies

RI S0024

Accident And Sickness Insurance Policies

RI H8171

Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.

RI H7503

Relating To Insurance

RI S2203

Relating To Insurance

WV SB615

Requiring certain health insurance providers cover treatment for certain pediatric autoimmune neuropsychiatric disorders